메뉴 건너뛰기




Volumn 85, Issue 10, 2013, Pages 1424-1432

Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models

Author keywords

Antiangiogenic agents; Antitumor activity; Heparanase inhibitor; Pediatric sarcomas; SST0001

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANTICOAGULANT AGENT; BEVACIZUMAB; FIBROBLAST GROWTH FACTOR 2; GLYCOSIDASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SST 0001; SUNITINIB; UNCLASSIFIED DRUG; VASCULOTROPIN;

EID: 84876689693     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.02.023     Document Type: Article
Times cited : (75)

References (41)
  • 1
    • 84860873205 scopus 로고    scopus 로고
    • Targeted therapy in bone and soft tissue sarcoma in children and adolescents
    • P.A. Thompson, and M. Chintagumpala Targeted therapy in bone and soft tissue sarcoma in children and adolescents Curr Oncol Rep 14 2012 197 205
    • (2012) Curr Oncol Rep , vol.14 , pp. 197-205
    • Thompson, P.A.1    Chintagumpala, M.2
  • 2
    • 79951646505 scopus 로고    scopus 로고
    • Pharmacotherapy for pediatric soft-tissue sarcomas
    • M. Casanova, and A. Ferrari Pharmacotherapy for pediatric soft-tissue sarcomas Expert Opin Pharmacother 12 2011 517 531
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 517-531
    • Casanova, M.1    Ferrari, A.2
  • 4
    • 77953019735 scopus 로고    scopus 로고
    • Targets for cancer therapy in childhood sarcomas
    • M. Wachtel, and B.W. Schafer Targets for cancer therapy in childhood sarcomas Cancer Treat Rev 36 2010 318 327
    • (2010) Cancer Treat Rev , vol.36 , pp. 318-327
    • Wachtel, M.1    Schafer, B.W.2
  • 5
    • 77956393743 scopus 로고    scopus 로고
    • New developments in targeted therapy for soft tissue sarcoma
    • K.N. Ganjoo New developments in targeted therapy for soft tissue sarcoma Curr Oncol Rep 12 2010 261 265
    • (2010) Curr Oncol Rep , vol.12 , pp. 261-265
    • Ganjoo, K.N.1
  • 6
    • 57549092526 scopus 로고    scopus 로고
    • The tumour microenvironment: A novel target for cancer therapy
    • E. Hanna, J. Quick, and S.K. Libutti The tumour microenvironment: a novel target for cancer therapy Oral Dis 15 2009 8 17
    • (2009) Oral Dis , vol.15 , pp. 8-17
    • Hanna, E.1    Quick, J.2    Libutti, S.K.3
  • 7
    • 79955528442 scopus 로고    scopus 로고
    • Extracellular matrix and cell signaling: The dynamic cooperation of integrin, proteoglycan and growth factor receptor
    • S-H. Kim, J. Turnbull, and S. Guimond Extracellular matrix and cell signaling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor J Endocrinol 209 2011 139 151
    • (2011) J Endocrinol , vol.209 , pp. 139-151
    • Kim, S.-H.1    Turnbull, J.2    Guimond, S.3
  • 8
    • 70349305403 scopus 로고    scopus 로고
    • Heparanase: Busy at the cell surface
    • L. Fux, N. Ilan, R.D. Sanderson, and I. Vlodavsky Heparanase: busy at the cell surface Cell 34 2009 511 519
    • (2009) Cell , vol.34 , pp. 511-519
    • Fux, L.1    Ilan, N.2    Sanderson, R.D.3    Vlodavsky, I.4
  • 9
    • 70149088868 scopus 로고    scopus 로고
    • Interactions between heparan sulfate and proteins-design and functional implications
    • U. Lindahl, and J.P. Li Interactions between heparan sulfate and proteins-design and functional implications Int Rev Cell Mol Biol 276 2009 105 159
    • (2009) Int Rev Cell Mol Biol , vol.276 , pp. 105-159
    • Lindahl, U.1    Li, J.P.2
  • 12
    • 79952728727 scopus 로고    scopus 로고
    • Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity
    • V.C. Ramani, Y. Yang, Y. Ren, L. Nan, and R.D. Sanderson Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity J Biol Chem 286 2011 6490 6499
    • (2011) J Biol Chem , vol.286 , pp. 6490-6499
    • Ramani, V.C.1    Yang, Y.2    Ren, Y.3    Nan, L.4    Sanderson, R.D.5
  • 13
    • 34547313009 scopus 로고    scopus 로고
    • Mammalian heparanase: What is the message
    • V. Vreys, and G. David Mammalian heparanase: what is the message J Cell Mol Med 11 2007 427 452
    • (2007) J Cell Mol Med , vol.11 , pp. 427-452
    • Vreys, V.1    David, G.2
  • 14
    • 70449604674 scopus 로고    scopus 로고
    • Heparin, heparan sulfate and heparanase in inflammatory reactions
    • J-P. Li, and I. Vlodavsky Heparin, heparan sulfate and heparanase in inflammatory reactions Thromb Haemost 102 2009 823 828
    • (2009) Thromb Haemost , vol.102 , pp. 823-828
    • Li, J.-P.1    Vlodavsky, I.2
  • 15
    • 33748683743 scopus 로고    scopus 로고
    • Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
    • N. Ilan, M. Elkin, and I. Vlodavsky Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis Int J Biochem Cell Biol 38 2006 2018 2039
    • (2006) Int J Biochem Cell Biol , vol.38 , pp. 2018-2039
    • Ilan, N.1    Elkin, M.2    Vlodavsky, I.3
  • 16
    • 34250366643 scopus 로고    scopus 로고
    • Heparanase enhances syndecan-1 shedding: A novel mechanism for stimulation of tumor growth and metastasis
    • Y. Yang, V. Macleod, H.Q. Miao, A. Theus, F. Zhan, and J.D. Shaughnessy Jr. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis J Biol Chem 282 2007 13326 13333
    • (2007) J Biol Chem , vol.282 , pp. 13326-13333
    • Yang, Y.1    MacLeod, V.2    Miao, H.Q.3    Theus, A.4    Zhan, F.5    Shaughnessy Jr., J.D.6
  • 17
    • 34247637147 scopus 로고    scopus 로고
    • Heparanase: A target for drug discovery in cancer and inflammation
    • E.A. McKenzie Heparanase: a target for drug discovery in cancer and inflammation Br J Pharmacol 151 2007 1 14
    • (2007) Br J Pharmacol , vol.151 , pp. 1-14
    • McKenzie, E.A.1
  • 18
    • 34447287858 scopus 로고    scopus 로고
    • Heparanase: Structure, biological fnctions and inhibition by heparin-derived mimetics of heparan sulfate
    • I. Vlodavsky, N. Ilan, A. Naggi, and B. Casu Heparanase: structure, biological fnctions and inhibition by heparin-derived mimetics of heparan sulfate Curr Pharm Des 13 2007 2057 2073
    • (2007) Curr Pharm des , vol.13 , pp. 2057-2073
    • Vlodavsky, I.1    Ilan, N.2    Naggi, A.3    Casu, B.4
  • 19
    • 84861706529 scopus 로고    scopus 로고
    • Targeting heparanase for cancer therapy at the tumor-matrix interface
    • R.D. Sanderson, and R.V. Iozzo Targeting heparanase for cancer therapy at the tumor-matrix interface Matrix Biol 31 2012 283 284
    • (2012) Matrix Biol , vol.31 , pp. 283-284
    • Sanderson, R.D.1    Iozzo, R.V.2
  • 20
    • 20144388264 scopus 로고    scopus 로고
    • Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting
    • A. Naggi, B. Casu, M. Perez, G. Torri, G. Cassinelli, and S. Penco Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting J Biol Chem 280 2005 12103 12113
    • (2005) J Biol Chem , vol.280 , pp. 12103-12113
    • Naggi, A.1    Casu, B.2    Perez, M.3    Torri, G.4    Cassinelli, G.5    Penco, S.6
  • 22
    • 79951676056 scopus 로고    scopus 로고
    • PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
    • K. Dredge, E. Hammond, P. Handley, T.J. Gonda, M.T. Smith, and C. Vincent PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models Br J Cancer 104 2011 635 642
    • (2011) Br J Cancer , vol.104 , pp. 635-642
    • Dredge, K.1    Hammond, E.2    Handley, P.3    Gonda, T.J.4    Smith, M.T.5    Vincent, C.6
  • 23
    • 79959266354 scopus 로고    scopus 로고
    • M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis
    • H. Zhou, S. Roy, E. Cochran, R. Zouaoui, C.L. Chu, and J. Duffner M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis PLoS ONE 6 2011 e21106
    • (2011) PLoS ONE , vol.6 , pp. 21106
    • Zhou, H.1    Roy, S.2    Cochran, E.3    Zouaoui, R.4    Chu, C.L.5    Duffner, J.6
  • 24
    • 79952731895 scopus 로고    scopus 로고
    • SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis
    • J.P. Ritchie, V.C. Ramani, Y. Ren, A. Naggi, G. Torri, and B. Casu SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis Clin Cancer Res 17 2011 1382 1393
    • (2011) Clin Cancer Res , vol.17 , pp. 1382-1393
    • Ritchie, J.P.1    Ramani, V.C.2    Ren, Y.3    Naggi, A.4    Torri, G.5    Casu, B.6
  • 26
    • 70349849375 scopus 로고    scopus 로고
    • Heparanase activity in alveolar and embryonal rhabdomyosarcoma: Implications for tumor invasion
    • V. Masola, C. Maran, E. Tassone, A. Zin, A. Rosolen, and M. Onisto Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion BMC Cancer 9 2009 304 313
    • (2009) BMC Cancer , vol.9 , pp. 304-313
    • Masola, V.1    Maran, C.2    Tassone, E.3    Zin, A.4    Rosolen, A.5    Onisto, M.6
  • 27
    • 84861234062 scopus 로고    scopus 로고
    • The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects
    • G. Cassinelli, V. Zuco, G. Petrangolini, M. De Cesare, M. Tortoreto, and C. Lanzi The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects Biochem Pharmacol 84 2012 163 171
    • (2012) Biochem Pharmacol , vol.84 , pp. 163-171
    • Cassinelli, G.1    Zuco, V.2    Petrangolini, G.3    De Cesare, M.4    Tortoreto, M.5    Lanzi, C.6
  • 28
    • 58349113405 scopus 로고    scopus 로고
    • Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: A putative mechanism
    • X. Zheng, F. Chu, P.M. Chou, C. Gallati, U. Dier, and B.L. Mirkin Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism Am J Physiol Cell Physiol 296 2009 C65 C74
    • (2009) Am J Physiol Cell Physiol , vol.296
    • Zheng, X.1    Chu, F.2    Chou, P.M.3    Gallati, C.4    Dier, U.5    Mirkin, B.L.6
  • 29
    • 16844366948 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: A therapeutic target for tumors of the Ewing's sarcoma family
    • S. Dalal, A.M. Berry, C.J. Cullinane, D.C. Mangham, R. Grimer, and I.J. Lewis Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family Clin Cancer Res 11 2005 2364 2378
    • (2005) Clin Cancer Res , vol.11 , pp. 2364-2378
    • Dalal, S.1    Berry, A.M.2    Cullinane, C.J.3    Mangham, D.C.4    Grimer, R.5    Lewis, I.J.6
  • 30
    • 65249103282 scopus 로고    scopus 로고
    • Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metallo proteinases
    • E. Zcharia, J. Jia, X. Zhang, L. Baraz, U. Lindahl, and T. Peretz Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metallo proteinases PLoS ONE 4 2009 e5181
    • (2009) PLoS ONE , vol.4 , pp. 5181
    • Zcharia, E.1    Jia, J.2    Zhang, X.3    Baraz, L.4    Lindahl, U.5    Peretz, T.6
  • 31
    • 57749101252 scopus 로고    scopus 로고
    • Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma
    • A. Purushothaman, L. Chen, Y. Yang, and R.D. Sanderson Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma J Biol Chem 283 2008 32628 32636
    • (2008) J Biol Chem , vol.283 , pp. 32628-32636
    • Purushothaman, A.1    Chen, L.2    Yang, Y.3    Sanderson, R.D.4
  • 32
    • 28044442504 scopus 로고    scopus 로고
    • Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies
    • R.D. Sanderson, Y. Yang, T. Kelly, V. MacLeod, Y. Dai, and A. Theus Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies J Cell Biochem 96 2005 897 905
    • (2005) J Cell Biochem , vol.96 , pp. 897-905
    • Sanderson, R.D.1    Yang, Y.2    Kelly, T.3    MacLeod, V.4    Dai, Y.5    Theus, A.6
  • 33
    • 77955055849 scopus 로고    scopus 로고
    • Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Racl pathway
    • S. Kamura, Y. Matsumoto, J-I. Fukushi, T. Fujiwara, K. Iida, and Y. Okada Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Racl pathway Br J Cancer 103 2010 370 381
    • (2010) Br J Cancer , vol.103 , pp. 370-381
    • Kamura, S.1    Matsumoto, Y.2    Fukushi, J.-I.3    Fujiwara, T.4    Iida, K.5    Okada, Y.6
  • 34
    • 77149144111 scopus 로고    scopus 로고
    • Antiangiogenesis agents in the treatment of soft tissue sarcomas
    • K. Ganjoo, and C. Jacobs Antiangiogenesis agents in the treatment of soft tissue sarcomas Cancer 116 2010 1177 1183
    • (2010) Cancer , vol.116 , pp. 1177-1183
    • Ganjoo, K.1    Jacobs, C.2
  • 35
    • 47149093742 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas
    • H.R. Park, K. Min, H.S. Kim, W.W. Jung, and Y.K. Park Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas Pathol Res Pract 204 2008 575 582
    • (2008) Pathol Res Pract , vol.204 , pp. 575-582
    • Park, H.R.1    Min, K.2    Kim, H.S.3    Jung, W.W.4    Park, Y.K.5
  • 36
    • 28544444282 scopus 로고    scopus 로고
    • Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid
    • M.F. Gee, R. Tsuchida, C. Eichler-Jonsson, B. Das, S. Barichel, and D. Malkin Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid Oncogene 24 2005 8025 8037
    • (2005) Oncogene , vol.24 , pp. 8025-8037
    • Gee, M.F.1    Tsuchida, R.2    Eichler-Jonsson, C.3    Das, B.4    Barichel, S.5    Malkin, D.6
  • 37
    • 10744225880 scopus 로고    scopus 로고
    • Undersulfated and glycol-split heparins endowed with antiangiogenic activity
    • B. Casu, M. Guerrini, S. Guglieri, A. Naggi, M. Perez, and G. Torri Undersulfated and glycol-split heparins endowed with antiangiogenic activity J Med Chem 47 2004 838 848
    • (2004) J Med Chem , vol.47 , pp. 838-848
    • Casu, B.1    Guerrini, M.2    Guglieri, S.3    Naggi, A.4    Perez, M.5    Torri, G.6
  • 38
    • 20844441407 scopus 로고    scopus 로고
    • Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist
    • C. Pisano, C. Aulicino, L. Vesci, B. Casu, A. Naggi, and G. Torri Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist Glycobiology 15 2005 1C 6C
    • (2005) Glycobiology , vol.15
    • Pisano, C.1    Aulicino, C.2    Vesci, L.3    Casu, B.4    Naggi, A.5    Torri, G.6
  • 39
    • 84861158485 scopus 로고    scopus 로고
    • Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors
    • Y. Bai, J. Li, B. Fang, A. Edwards, G. Zhang, and M. Bui Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors Cancer Res 72 2012 2501 2511
    • (2012) Cancer Res , vol.72 , pp. 2501-2511
    • Bai, Y.1    Li, J.2    Fang, B.3    Edwards, A.4    Zhang, G.5    Bui, M.6
  • 40
    • 67349218119 scopus 로고    scopus 로고
    • Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell
    • E. Charytonowicz, C. Cordon-Cardo, I. Matushansky, and M. Ziman Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell Cancer Lett 279 2009 126 136
    • (2009) Cancer Lett , vol.279 , pp. 126-136
    • Charytonowicz, E.1    Cordon-Cardo, C.2    Matushansky, I.3    Ziman, M.4
  • 41
    • 84860366086 scopus 로고    scopus 로고
    • Antiangiogenic therapy-evolving view based on clinical trial results
    • G.C. Jayson, D.J. Hicklin, and L.M. Ellis Antiangiogenic therapy-evolving view based on clinical trial results Nature Rev 9 2012 297 303
    • (2012) Nature Rev , vol.9 , pp. 297-303
    • Jayson, G.C.1    Hicklin, D.J.2    Ellis, L.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.